Healthcare coverage initiations roundup

|By:, SA News Editor

Piper starts Celgene (CELG) at Neutral.

Repros Therapeutics (RPRX) initiated at Overweight at Piper. Price target is $26.

Piper starts Gilead (GILD) at Overweight. Price target is $91.

Incyte (INCY) initiated at Overweight at Piper. Price target is $56.

Piper starts Insmed (INSM) at Overweight. Price target is $34.

Piper starts MannKind (MNKD) at Neutral.

Nektar Therapeutics (NKTR) is initiated at Overweight at Piper. Price target is $20.

Amgen (AMGN) initiated at Overweight at Piper. Price target is $143.

Vanda (VNDA) started at Overweight at Piper. Price target is $21.

Piper initiates Pharmacyclics (PCYC) at Overweight. Price target is $160.

Piper upgrades Isis Pharmaceuticals (ISIS) to Neutral from Underweight.

Piper starts Alexion (ALXN) at Overweight. Price target is $172.